Early antiinflammatory therapy attenuates brain damage after sah in rats
Author:
Vadokas Georg12, Koehler Stefan1, Weiland Judith1, Lilla Nadine1, Stetter Christian1, Westermaier Thomas1
Affiliation:
1. Department of Neurosurgery, University Hospital Würzburg , Josef-Schneider-Straße 11, 97080 Würzburg , Germany 2. Department of Urology, Canisius Wilhelmina Hospital Nijmegen, Weg door Jonkerbos 100, 6532 SZ Nijmegen , Netherlands
Abstract
Abstract
Background
Early inflammatory processes may play an important role in the development of early brain injury (EBI) after subarachnoid hemorrhage (SAH). Experimental studies suggest that anti-inflammatory and membrane-stabilizing drugs might have beneficial effects, although the underlying mechanisms are not fully understood. The aim of this study was to investigate the effect of early treatment with methylprednisolone and minocycline on cerebral perfusion and EBI after experimental SAH.
Methods
Male Sprague-Dawley rats were subjected to SAH using the endovascular filament model. 30 minutes after SAH, they were randomly assigned to receive an intravenous injection of methylprednisolone (16mg/kg body weight, n=10), minocycline (45mg/kg body weight, n=10) or saline (n=11). Mean arterial blood pressure (MABP), intracranial pressure (ICP) and local cerebral blood flow (LCBF) over both hemispheres were recorded continuously for three hours following SAH. Neurological assessment was performed after 24 hours. Hippocampal damage was analyzed by immunohistochemical staining (caspase 3).
Results
Treatment with methylprednisolone or minocycline did not result in a significant improvement of MABP, ICP or LCBF. Animals of both treatment groups showed a non-significant trend to better neurological recovery compared to animals of the control group. Mortality was reduced and hippocampal damage significantly attenuated in both methylprednisolone and minocycline treated animals.
Conclusion
The results of this study suggest that inflammatory processes may play an important role in the pathophysiology of EBI after SAH. Early treatment with the anti-inflammatory drugs methylprednisolone or minocycline in the acute phase of SAH has the potential to reduce brain damage and exert a neuroprotective effect.
Publisher
Walter de Gruyter GmbH
Subject
General Neuroscience
Reference56 articles.
1. Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A et al., Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2), Lancet Neurol 2011, 10, 618-625. 2. Sehba FA, Pluta RM, Zhang JH, Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury, Mol Neurobiol 2011, 43, 27-40. 3. van Donkelaar CE, Bakker NA, Veeger NJ, Uyttenboogaart M, Metzemaekers JD, Eshghi O et al., Prediction of outcome after subarachnoid hemorrhage: timing of clinical assessment, J Neurosurg 2017, 126, 52-59. 4. Suwatcharangkoon S, Meyers E, Falo C, Schmidt JM, Agarwal S, Claassen J et al., Loss of Consciousness at Onset of Subarachnoid Hemorrhage as an Important Marker of Early Brain Injury, JAMA Neurol 2016, 73, 28-35. 5. Schubert GA, Schilling L, Thome C, Clazosentan, an endothelin receptor antagonist, prevents early hypoperfusion during the acute phase of massive experimental subarachnoid hemorrhage: a laser Doppler flowmetry study in rats, J Neurosurg 2008, 109, 1134-1140.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|